The European Society for Medical Oncology (ESMO) will host the ESMO congress 2022 September 9-13, 2022. LamKap Bio alpha is very pleased to present for the first time preclinical data on the development of NILK-2301 (CEAxCD3) and NILK-3301 (CEAxCD28) bispecific antibodies for immunotherapy of patients with carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5 aka CEA) expressing solid tumors.
“Novel CEAxCD3 (NILK-2301) and CEAxCD28 (NILK-3301) κλ bispecific antibodies for next generation immunotherapy of CEA-expressing cancer” will be presented on site in Hall 4 (poster area) on September 12 (presentation no. 752P).
Paris Expo Porte de Versailles 1 Pl. de la Porte de Versailles, 75015 Paris, France
